How Diagnostic Technologies and Biomarkers Improve Treatment Decisions for People Living with Cancer

Mark G. Kris, MD

William and Joy Ruane Chair in Thoracic Oncology, Attending Physician, Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

Tanios Bekaii-Saab, MD, FACP

Leader, Gastrointestinal Cancer Program, Mayo Clinic Cancer Center, Professor, Mayo Clinic College of Medicine and Science, Consultant, Mayo Clinic in Arizona

Sarah E. Kerr, MD

Pathologist, Hospital Pathology Associates, P.A., Divisions of Cytopathology; Gynecologic and Perinatal Pathology; Molecular Diagnostic Lead Pathologist for Next Generation Sequencing Development and Practice; Allina Health Laboratory (A Part of Abbott Northwestern Hospital), Minneapolis, MN

Tara Burke, PhD

Senior Director of Public Policy and Advocacy, Association for Molecular Pathology (AMP)

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare